With a $32 million loan in hand, AgaMatrix said this week it plans to reorganize the companies into two entities – AgaMatrix, Inc. and WaveForm Technologies. The holding company raised $32 million from Prospect Capital Corp. and said it will use the funds to support sales and marketing, product development and clinical trial activities for its […]
Patient Monitoring
Why Bigfoot Biomedical’s CEO thinks the diabetes industry has a data problem
Bigfoot Biomedical‘s chief executive is excited about Abbott‘s (NYSE:ABT) latest regulatory win – and it’s not just because the two companies have an established partnership. Yesterday, the FDA approved Abbott’s FreeStyle Libre Flash continuous glucose monitoring system. It’s the first device of its kind, allowing patients to track their blood glucose levels without the use […]
Dexcom CEO: Bringing meaningful data to the diabetes community
Kevin Sayer describes Dexcom‘s (NSDQ:DXCM) history as punctuated by “firsts” – its continuous glucose meter was the first to connect to a phone. Last year, the company’s tool became the first approved by the FDA as one from which a patient with diabetes can make insulin dosing decisions. When Sayer took the helm as president & […]
Sanofi, Innovation Health to evaluate digital health solutions for Type II diabetes
Innovation Health and Sanofi (NYSE:SNY) said today that the companies are launching a pilot program to evaluate the impact of digital health solutions from One Drop and Common Sensing for people with Type II diabetes. The program hopes to enable pharmaceutical companies, tech companies and plan providers to work together to improve patient outcomes, according to […]
Nemaura Medical touts interim data from next-gen SugarBeat trials
Nemaura Medical touted interim data today from the European clinical trial program evaluating its wireless, adhesive skin-patch for use as a non-invasive and needle-free glucose monitoring system. The clinical trial program enrolled 75 patients, who continuously wore the 2nd-gen SugarBeat device for up to 14 hours per day over the course of seven days in […]
DarioHealth joins Philips-backed accelerator for development of diabetes management tech
DarioHealth (NSDQ:DRIO) said today that it inked a strategic collaboration with Philips (NYSE:PHG)-backed accelerator, HighTechXL. The Netherlands-based program chose DarioHealth “because of its strong management team, innovative business model and smart solutions for diabetes management,” the company said. The three-month program is designed to accelerate startups into the next stage of development. Collaborating with HighTechXL could help […]
Dexcom launches program to connect CGM data with 3rd-party apps
Dexcom (NSDQ:DXCM) today launched a public API that allows 3rd-party developers to connect patient-authorized continuous glucose monitoring data into software apps. The data-sharing platform is designed to make use of the blood glucose data produced by Dexcom’s CGM systems. Companies, including One Drop, have begun accessing the API and others in the U.S. can register online, […]
Abbott nabs U.K. reimbursement win for FreeStyle Libre CGM
Abbott (NYSE:ABT) said today that its FreeStyle Libre continuous glucose monitoring system will be available for reimbursement in the U.K., starting on Nov. 1. The company’s system is designed to automatically read glucose levels through a sensor that’s worn on the back of a person’s upper arm for up to 14 days, thereby eliminating routine finger […]
Roche buys mySugr diabetes app
Swiss drugmaker Roche (PINK:RHHBY) said today that it bought diabetes management platform mySugr for an undisclosed price. The 2 companies have worked together since 2014. mySugr’s digital tech enables users to track things like their blood sugar, diabetes medications and physical activity. Roche’s diabetes diagnostic biz has recently faced pricing pressure, bringing about rumors that it […]
BTG touts digital patient engagement platform with TheraSphere treatment
BTG (LON:BTG) touted data last week from a pilot study of its digital patient engagement platform IO Loop in patients with primary hepatocellular carcinoma undergoing treatment with the company’s TheraSphere transarterial radioembolization therapy. The study found that patients experienced sustained quality of life up to 3 months after treatment. The company touted the study of […]